What: A retrospective study discovered that women who used GLP-1 receptor agonists in the two years before conception were less likely to develop high blood pressure, gestational diabetes, preterm birth, or require a C‑section. Researchers now hope to study patients prospectively to confirm these findings.
Key line: “Relatively little is known how preconception GLP-1 receptor agonist use may impact pregnancy outcomes… This study suggests that [GLP-1s] may have potential to be a powerful tool to optimize preconception health,” said Dr. Christopher T. Nau.
Source: Healio